Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy
Abstract In the era of immunotherapy, there lacks of a reliable genomic predictor to identify optimal patient populations in combined radiotherapy and immunotherapy (CRI). The purpose of this study is to investigate whether genomic scores defining radiosensitivity are associated with immune response...
Enregistré dans:
Auteurs principaux: | Yang-Hong Dai, Ying-Fu Wang, Po-Chien Shen, Cheng-Hsiang Lo, Jen-Fu Yang, Chun-Shu Lin, Hsing-Lung Chao, Wen-Yen Huang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4214af13ccb94d3a95aa527a65bc27ae |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Application of Radiosensitizers in Cancer Radiotherapy
par: Gong L, et autres
Publié: (2021) -
Au-Pt Nanoparticle Formulation as a Radiosensitizer for Radiotherapy with Dual Effects
par: Yang S, et autres
Publié: (2021) -
Novel emerging biomarkers to immunotherapy in kidney cancer
par: Yasser Ged, et autres
Publié: (2021) -
Mutation load estimation model as a predictor of the response to cancer immunotherapy
par: Guan-Yi Lyu, et autres
Publié: (2018) -
Olaparib nanoparticles potentiated radiosensitization effects on lung cancer
par: Wu M, et autres
Publié: (2018)